Philips has recalled several models of its Trilogy ventilators due to software and hardware issues that pose serious risks to patients. The problems include inaccurate oxygen delivery readings, false power loss alarms, and blockages caused by dust buildup, which can impede airflow. These malfunctions have been linked to nine injuries and one death.
To address these issues, Philips has released a software update and now requires the use of approved particulate filters. This recall, which affects about 90,000 units globally (67,000 in the U.S.), aims to fix both new and previously reported safety concerns. Philips advises users not to use the ventilators until the software update has been installed. The recall impacts models including Trilogy Evo, EV300, Evo O2, and Evo Universal.
This recall follows a broader recall of Philips respiratory devices due to soundproofing foam that could degrade and be inhaled by patients. Philips is working with the FDA and other authorities to rectify these issues and ensure patient safety